{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002384","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001379574","attributes":{"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"20 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["214"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/172CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"725M","NAME":"S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160324.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/172CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160324.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"04058ee36b8421220fe78398f6365bb2"},{"FORMAT":"bigBed","SIZE":"1.8M","NAME":"S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/172CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"f995f20c85a3c2ff800f7e5754b879e3"},{"FORMAT":"BED","SIZE":"1.8M","NAME":"S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/172CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"ed5ff08e8fde41bad8c0f75693408cd4"},{"FORMAT":"Text","SIZE":"2.0M","NAME":"S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/172CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01QB7H1.ERX1384840.H3K27ac.bwa.GRCh38.20160701.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"317d21ed9435a214702e0e83558a1da9"}],"dataset_id":"EGAD00001002384","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"172CLL","sample_barcode":"S01QB7H1","attributes":{"DONOR_HEALTH_STATUS":["Chronic Lymphocytic Leukemia"],"DONOR_AGE":["75 - 80"],"MOLECULE":["genomic DNA"],"DISEASE":["Chronic Lymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0023434"}],"SUBJECT_ID":["172CLL"],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["female"],"DONOR_ID":["172CLL"],"DONOR_SEX":["Female"]},"SAMPLE_ID":"EGAN00001360102","SAMPLE_DESCRIPTION":"Chronic Lymphocytic Leukemia"}}